Hematology and Blood Disorders

Review Article P.28-30

The critical push for traceability compliance: A District General Hospital experience

Author(s): Francis Ajeneye

DOI: 10.35841/blood-disorders.3.2.28-30

Abstract Full Text PDF

Short Communication P.31-32

Eosinopenia as a Diagnostic Marker in Covid-19?

Author(s): Francis Ajeneye, Oladimeji Olofin

DOI: 10.35841/blood-disorders.3.2.31-32

Abstract Full Text PDF

Market Analysis P.16-19

Breakthrough notions in Hematology and Transfusion Medicine: Market Scrutiny

Author(s): Shimon Slavin

DOI: 10.35841/blood-disorders.3.2.16-19

Full Text PDF

Commentary P.33-35

Gemcitabine-carbon nitride dots as nanocarrier to target specifically pediatric glioma tumors

Author(s): Roger M. Leblanc, Piumi Y. Liyanage

DOI: 10.35841/blood-disorders.3.2.33-35

Abstract Full Text PDF

Editor Note P.36-37

Advances in the field of hematology

Author(s): Ankit Trivedi

DOI: 10.35841/blood-disorders.3.2.36-37

Full Text PDF